scholarly article | Q13442814 |
P356 | DOI | 10.1007/S00210-013-0940-6 |
P698 | PubMed publication ID | 24297249 |
P50 | author | Erik Qvigstad | Q63762835 |
P2093 | author name string | Finn Olav Levy | |
Jan-Bjørn Osnes | |||
Tor Skomedal | |||
Trond Bach | |||
Jon Riise | |||
Stine Bergholtz | |||
P2860 | cites work | Inhibition of beta- but not alpha 1-mediated adrenergic responses in isolated hearts and cardiomyocytes by nitric oxide and 8-bromo cyclic GMP | Q71706666 |
Comparison between alpha-1 adrenoceptor-mediated and beta adrenoceptor-mediated inotropic components elicited by norepinephrine in failing human ventricular muscle | Q73045813 | ||
Phosphodiesterase III inhibitors for heart failure | Q24244978 | ||
Structural insights into the ligand binding domains of membrane bound guanylyl cyclases and natriuretic peptide receptors | Q28216173 | ||
Effect of nesiritide in patients with acute decompensated heart failure | Q28242547 | ||
Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials | Q28246006 | ||
Cardiac hypertrophy in transgenic rats expressing a dominant-negative mutant of the natriuretic peptide receptor B. | Q28569799 | ||
Development of a selective peptide antagonist for the human natriuretic peptide receptor-B. | Q31141579 | ||
5HT4(a) and 5-HT4(b) receptors have nearly identical pharmacology and are both expressed in human atrium and ventricle | Q32059490 | ||
Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group | Q33157410 | ||
Design of chemical libraries with potentially bioactive molecules applying a maximum common substructure concept | Q33494087 | ||
Allosteric binding sites on cell-surface receptors: novel targets for drug discovery | Q34139176 | ||
Cyclic guanosine monophosphate signaling and phosphodiesterase-5 inhibitors in cardioprotection | Q34277031 | ||
Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications | Q34906050 | ||
Agents increasing cyclic GMP amplify 5-HT4-elicited positive inotropic response in failing rat cardiac ventricle | Q35563508 | ||
Cardioprotective actions of cyclic GMP: lessons from genetic animal models | Q36164755 | ||
The role of natriuretic peptides in cardioprotection | Q36313449 | ||
Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions | Q36314468 | ||
Natriuretic peptide C receptor signalling in the heart and vasculature | Q37002318 | ||
Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders | Q37360436 | ||
Cyclic GMP-dependent signaling in cardiac myocytes | Q38025552 | ||
Ring-deleted analogs of atrial natriuretic factor inhibit adenylate cyclase/cAMP system. Possible coupling of clearance atrial natriuretic factor receptors to adenylate cyclase/cAMP signal transduction system | Q41733809 | ||
Protein kinase G-dependent cardioprotective mechanism of phosphodiesterase-5 inhibition involves phosphorylation of ERK and GSK3beta | Q41817597 | ||
Hormone-stimulated desensitization of hormone-dependent adenylyl cyclase. Dual action of luteninizing hormone on pig graafian follicle membranes | Q42443756 | ||
Dynamics of atrial natriuretic factor-guanylate cyclase receptors and receptor-ligand complexes in cultured glomerular mesangial and renomedullary interstitial cells | Q43625344 | ||
Influence of phosphodiesterases and cGMP on cAMP generation and on phosphorylation of phospholamban and troponin I by 5-HT4 receptor activation in porcine left atrium | Q44824819 | ||
Cardiac PDEs and crosstalk between cAMP and cGMP signalling pathways in the regulation of contractility | Q46599816 | ||
A highly sensitive adenylate cyclase assay | Q47871494 | ||
Natriuretic peptides increase beta1-adrenoceptor signalling in failing hearts through phosphodiesterase 3 inhibition | Q48412668 | ||
Study of the regulation of the inotropic response to 5-HT4 receptor activation via phosphodiesterases and its cross-talk with C-type natriuretic peptide in porcine left atrium | Q49168980 | ||
Cardiac production of C-type natriuretic peptide in heart failure | Q60570705 | ||
P433 | issue | 1 | |
P304 | page(s) | 5-14 | |
P577 | publication date | 2013-12-03 | |
P1433 | published in | Naunyn-Schmiedeberg's Archives of Pharmacology | Q1468251 |
P1476 | title | Identification of small molecule NPR-B antagonists by high throughput screening--potential use in heart failure | |
P478 | volume | 387 |
Search more.